Literature DB >> 9840394

Primary juxtacortical chondrosarcoma dedifferentiating after 20 years.

S M Kumta1, J F Griffith, L T Chow, P C Leung.   

Abstract

We present the clinical, radiographic and pathological features of a juxtacortical chondrosarcoma which underwent dedifferentiation to an osteosarcoma in a 47-year-old woman. The tumour, abutting the femoral diaphysis, had initially presented 20 years earlier. Local excision was performed at presentation and again 10 years later, but the tumour recurred on each occasion. Serial radiographs showed cortical saucerisation evolving to cortical buttressing and mounding. After 20 years a dramatic radiographic change heralded tumour dedifferentiation.

Entities:  

Mesh:

Year:  1998        PMID: 9840394     DOI: 10.1007/s002560050439

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  5 in total

Review 1.  Dedifferentiated fat cells: A cell source for regenerative medicine.

Authors:  Medet Jumabay; Kristina I Boström
Journal:  World J Stem Cells       Date:  2015-11-26       Impact factor: 5.326

2.  Periosteal chondrosarcoma in a 9-year-old girl with osteochondromatosis.

Authors:  Jacob Weinberg; Theodore T Miller; John E Handelsman; Leonard B Kahn; David H Godfried; Samuel Kenan
Journal:  Skeletal Radiol       Date:  2005-02-19       Impact factor: 2.199

3.  Dedifferentiated chondrosarcoma--a fatal disease.

Authors:  J Bruns; W Fiedler; M Werner; G Delling
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-23       Impact factor: 4.553

4.  Bony metastases following complete resection of periosteal chondrosarcoma.

Authors:  Xiwei Liu; Li Min; Ganjun Chen; Song Hong; Chongqi Tu
Journal:  World J Surg Oncol       Date:  2015-03-26       Impact factor: 2.754

5.  Usefulness of PET/CT for diagnosis of periosteal chondrosarcoma of the femur: A case report.

Authors:  Shota Morimoto; Hiroyuki Futani; Konan Tsuchiyama; Satoru Fukunaga; Yoshitane Tsukamoto; Shinichi Yoshiya
Journal:  Oncol Lett       Date:  2014-03-28       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.